SecBot SecBot

EMBC

Embecta Corp.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001872789 Healthcare & Medical Devices
$6.68 −0.03 (−0.37%)
Oct 26 4:00 PM ET · prev $6.71
Market cap
$388.7M
Small cap
Median target
$4.00
−40% · range $3.00–5.00
Next earnings
Nov 23
in 28 days · EPS est. $0.29
1 year
−52.5%
from $14.07 · Oct 27
30 days
+12.7%
from $5.93
52-week range
$2.90–14.64
−54% from high · low May 19
Avg volume 20D
894.7K
shares / day
Short interest
5.83M
≈10.3% of shares · +5.0%
Days to cover
5.4
at average volume
Insider net
+$521.0K
4 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 1 exit
Filing reports
10
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 1 bearish · 1 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/5 ·Next Earnings date, Nov 23, 2026
Strongest BEARISH A significant institutional cluster in Embecta Corp. (EMBC) for Q2 2026 shows a net bearish imbalance: 29…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    4 insiders bought $557.9K at an average $4.85. 1 insider sold $37.0K. Price is 38% above their cost.

  • InstitutionsMIXED

    Q2 2026: 28 added (0 new), 29 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.353 → $0.290 over 90 days. 0 up, 3 down in 30 days.

  • Short sellersSTEADY

    Short interest +5.0% to 5.83M shares. 5.4 days to cover, ≈10.3% of shares.

  • TrendUPTREND

    19% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
1
exit
FundMoveSharesValue
BlackRock, Inc.TRIM4,599,771$15.0M
AMERIPRISE FINANCIAL INCDOUBLED2,038,731$6.6M
MORGAN STANLEYDOUBLED1,996,747$6.5M
STATE STREET CORPTRIM1,610,666$5.3M
GOLDMAN SACHS GROUP INCADD1,162,041$3.8M
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM1,098,389$3.6M
MILLENNIUM MANAGEMENT LLCTRIM945,968$3.1M
UBS Group AGADD829,099$2.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
12-month targets · 2 analysts

Price is above the highest target. Median implies −40%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
May 18, 2026B of A Securities
MAINTAIN
MAINTAINUnderperform
May 6, 2026Mizuho
MAINTAIN
MAINTAINNeutral
May 6, 2026BTIG
DOWNGRADE
DOWNGRADENeutral

Insider ledger

Form 4
$557.9K
bought · 4 insiders
$37.0K
sold · 1 insider
+37.8%
vs their $4.85 cost
DateInsiderTypeValue
Sep 4, 2026
Morris Milton Mayo
Director
SELL$37.0K
Aug 12, 2026
HOMBACH ROBERT J.
Director
BUY$223.8K
Aug 12, 2026
Mann Jeffrey Z
Pres, Pharm Svc&Prod Mgmt, CLO
BUY$99.8K
Aug 12, 2026
Elguicze Jacob
SVP and CFO
BUY$93.4K
Aug 12, 2026
Kurdikar Devdatt
President and CEO
BUY$140.9K
Aug 9, 2026
Casner Jean
Chief Human Resources Officer
TAX W/H$6.5K
Jun 1, 2026
Roth Anthony M.
VP, Chief Accounting Officer
AWARD30,000 sh
Feb 11, 2026
Pomeroy Claire
Director
AWARD22,841 sh

Earnings setup

Estimates
Nov 23
reports in 28 days
$0.29
EPS estimate, this quarter
−18%
estimate change, 90 days
0↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.29$0.28–$0.31+0.0%$269.7M
Next Q$0.49$0.39–$0.67+2.8%$268.0M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
5,825,802
shares short
+5.0%
vs prior settlement
5.4
days to cover
≈10.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 22, 2026 SEC
A significant institutional cluster in Embecta Corp. (EMBC) for Q2 2026 shows a net bearish imbalance: 29 sellers…
INST-CLUSTER — Impact 4/10
Sep 4, 2026 SEC
Director Morris Milton Mayo filed a Form 144 on September 4, 2026, indicating intent to sell 6,293 shares of Embecta…
144 — Impact 2/10
Sep 4, 2026 Insider
Morris Milton Mayo sold 6,293 shares
Director @ $5.88 ($37.0K)
Aug 31, 2026 Other
embecta to Participate in Investor Events
In September, embecta will participate in the Wells Fargo 2026 Healthcare Conference and the J.P. Mo
Aug 13, 2026 SEC
Embecta Corp. (EMBC) insiders, including the CEO, CFO, and a director, made open-market purchases totaling $558K on…
CLUSTER — Impact 5/10
Aug 12, 2026 Insider
HOMBACH ROBERT J. bought 45,000 shares
Director @ $4.97 ($223.8K)
Aug 12, 2026 Insider
Mann Jeffrey Z bought 20,000 shares
Pres, Pharm Svc&Prod Mgmt, CLO @ $4.99 ($99.8K)
Aug 7, 2026 Press
Embecta's board declared a $0.01 quarterly dividend, a nominal payout reflecting the company's small market cap and…
Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 23, 2026
Earnings date
EMBC Q4 2026 Earnings Before Market Open — 2026-11-23
Recent
Aug 31, 2026
Press release
embecta to Participate in Investor Events
In September, embecta will participate in the Wells Fargo 2026 Healthcare Conference and the J.P. Morgan 4th Annual Nashville Healthcare Conference…
Aug 17, 2026
Press release
EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit
NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp…
Aug 17, 2026
Press release
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of…
Aug 17, 2026
Press release
Embecta Corp. Sued for Securities Law Violations - FINAL DEADLINE TODAY - EMBC
LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the…
Aug 14, 2026
Press release
Embecta Corp. (EMBC) Investors: August 17, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman
SAN FRANCISCO, Aug. 14, 2026 /PRNewswire/ -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into…

SecBot reports

10 filings · 3 press releases · 2 bullish · 2 bearish · 2 mixed · 4 neutral
All EMBC filing & press-release reports (13)